# Lyne Laboratories, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c

> Inspection records and compliance data for Lyne Laboratories, Inc. in Brockton, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: Lyne Laboratories, Inc.
- FEI Number: 1000513191
- City: Brockton
- State: Massachusetts
- Country Name: United States
- Address Line 1: 10 Burke Dr
- Zip Code: 02301
- Business Operations: FDF MANUFACTURE

## Related Documents

- [FDA Inspection 1306884 - Lyne Laboratories, Inc. - 2026-03-10](https://www.keypedia.com/records/fda_inspections/lyne-laboratories-inc/df0c3cb3-fb52-41ec-b176-a22d4e1c4bba) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 10, 2026
- [483 - Lyne Laboratories, Inc. - 2022-10-21](https://www.keypedia.com/records/483/lyne-laboratories-inc/eca42796-26bd-4361-9df3-c0134d5b57f4) — source: FDA, date: October 21, 2022
- [FDA Inspection 1182001 - Lyne Laboratories, Inc. - 2022-10-21](https://www.keypedia.com/records/fda_inspections/lyne-laboratories-inc/3658da10-6945-42f6-913c-925867ca3f56) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 21, 2022
- [FDA Inspection 1152572 - Lyne Laboratories, Inc. - 2021-09-08](https://www.keypedia.com/records/fda_inspections/lyne-laboratories-inc/5b964a73-e1f4-4d6f-aa31-40ec87f5b9e5) — classification: No Action Indicated (NAI), source: FDA, date: September 8, 2021
- [EIR - Lyne Laboratories, Inc. - 2021-09-07](https://www.keypedia.com/records/eir/lyne-laboratories-inc/1135dafc-6774-4eb2-bf03-3d997c8c8c40) — source: FDA, date: September 7, 2021
- [EIR - Lyne Laboratories, Inc. - 2018-01-25](https://www.keypedia.com/records/eir/lyne-laboratories-inc/b13e74cd-d476-49db-a5fb-3bbc51651e3b) — source: FDA, date: January 25, 2018
- [FDA Inspection 1038819 - Lyne Laboratories, Inc. - 2018-01-25](https://www.keypedia.com/records/fda_inspections/lyne-laboratories-inc/4442e28e-c441-4696-9b59-028352c1ecdf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 25, 2018
- [FDA Inspection 1026803 - Lyne Laboratories, Inc. - 2017-09-07](https://www.keypedia.com/records/fda_inspections/lyne-laboratories-inc/fa3c3de1-a859-429e-b7a8-9663fc187566) — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2017
- [FDA Inspection 983497 - Lyne Laboratories, Inc. - 2016-08-17](https://www.keypedia.com/records/fda_inspections/lyne-laboratories-inc/9a3179d0-c534-4a79-b260-24cd70c6ee0d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 17, 2016
- [FDA Inspection 865986 - Lyne Laboratories, Inc. - 2014-02-13](https://www.keypedia.com/records/fda_inspections/lyne-laboratories-inc/e72b846f-db71-450c-a40e-bee48e81a28f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 13, 2014
- [FDA Inspection 713089 - Lyne Laboratories, Inc. - 2011-03-25](https://www.keypedia.com/records/fda_inspections/lyne-laboratories-inc/f665ea98-6433-4025-905d-9b4c3aa8ba07) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2011
- [FDA Inspection 655770 - Lyne Laboratories, Inc. - 2010-04-05](https://www.keypedia.com/records/fda_inspections/lyne-laboratories-inc/e684e1a1-69b6-4d38-ac8b-9642e32104d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 5, 2010
- [FDA Inspection 570569 - Lyne Laboratories, Inc. - 2009-02-26](https://www.keypedia.com/records/fda_inspections/lyne-laboratories-inc/e7da4582-93d3-41f6-8a2d-89cada97070c) — classification: Official Action Indicated (OAI), source: FDA, date: February 26, 2009

## Related Companies

- [Abraxis Bioscience, LLC](https://www.keypedia.com/companies/abraxis-bioscience-llc/5751a531-276f-4635-9289-30cacf498d86)
- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/12f42026-6a34-4cfe-936d-3646a0e34c8d)
- [DPT Laboratories, Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/0a6b4d0a-ad7e-4f4f-ab10-34e0ef9913d4)
- [Catalent CTS, LLC](https://www.keypedia.com/companies/catalent-cts-llc/db17ec22-68a4-42be-86e9-4c1410a493a8)
- [Ultradent Products, Inc.](https://www.keypedia.com/companies/ultradent-products-inc/16b4d8af-54bd-48d3-acc8-a5169bd5bfe3)
- [Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company](https://www.keypedia.com/companies/bristol-myers-squibb-holdings-pharma-ltd-liability-company/64a65e7b-7328-491c-8b08-cc8f2e018968)
- [Bushu Pharmaceuticals Ltd.](https://www.keypedia.com/companies/bushu-pharmaceuticals-ltd/f3ccab51-b6fa-4873-b2de-61ba32d7967e)
- [AMO (Hangzhou) Co., Ltd.](https://www.keypedia.com/companies/amo-hangzhou-co-ltd/00c065f6-3b50-4050-811e-d03ad3d646e9)
- [WES Pharma Inc.](https://www.keypedia.com/companies/wes-pharma-inc/26195242-bcfc-4382-817b-4d9d153b962d)
- [Laboratorios Liconsa SAU](https://www.keypedia.com/companies/laboratorios-liconsa-sau/ab88a2bb-8c52-445d-8417-82ea8f48bdf6)

## Related Officers

- [company_representative](https://www.keypedia.com/people/david-l-english/16f9419b-6dfa-48b5-a9c2-8ddfe8935002)
- [Program Division Director/District Director](https://www.keypedia.com/people/jonathan-g-matrisciano/17e5bce2-75a6-4182-925d-b94b42763dd2)
- [Robert Crisafi](https://www.keypedia.com/people/robert-crisafi/08ea9792-2d9b-409e-bc11-383da2a4bac3)
- [Gerard D. Difiore](https://www.keypedia.com/people/gerard-d-difiore/7e4f49b4-dc8a-4d82-9547-613c83e97fb6)
- [M.S., Consumer Safety Officer at FDA](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)